検索結果 - Maxime Dougados

結果の絞り込み
  1. 1
    Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial

    Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial 著者: Maxime Dougados

    出版事項 1999
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

    EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees 著者: Maxime Dougados

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.

    Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. 著者: Maxime Dougados, H Awada, B Amor

    出版事項 1988
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials

    Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials 著者: Jérôme Avouac, Laure Gossec, Maxime Dougados

    出版事項 2007
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  5. 5
    Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.

    Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. 著者: Maxime Dougados, P. Boumier, B Amor

    出版事項 1986
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomized controlled trial

    Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomized controlled trial 著者: Minh Nguyen, Michel Revel, Maxime Dougados

    出版事項 1997
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein

    Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein 著者: Mathilde Benhamou, Laure Gossec, Maxime Dougados

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Reporting of Adherence to Medication in Recent Randomized Controlled Trials of 6 Chronic Diseases: A Systematic Literature Review

    Reporting of Adherence to Medication in Recent Randomized Controlled Trials of 6 Chronic Diseases: A Systematic Literature Review 著者: Laure Gossec, Maxime Dougados, Florence Tubach, Philippe Ravaud

    出版事項 2007
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations ‘Not everything that glisters is gold (standard)’

    MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations ‘Not everything that glisters is gold (standard)’ 著者: Cédric Lukas, C. Cyteval, Maxime Dougados, Ulrich Weber

    出版事項 2018
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  10. 10
    Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients

    Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients... 著者: X Ayral, EH Pickering, Thasia Woodworth, N. Mackillop, Maxime Dougados

    出版事項 2005
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis

    Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis 著者: Natalia Bello, Adrien Etcheto, Caroline Béal, Maxime Dougados, Anna Moltó

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Ultrasonic Backscatter and Transmission Parameters at the Os Calcis in Postmenopausal Osteoporosis

    Ultrasonic Backscatter and Transmission Parameters at the Os Calcis in Postmenopausal Osteoporosis 著者: Christian Roux, V. Roberjot, Raphaël Porcher, S. Kolta, Maxime Dougados, Pascal Laugier

    出版事項 2001
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

    Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials 著者: Joachim Sieper, Benjamin Porter-Brown, Liz Thompson, Olivier Harari, Maxime Dougados

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

    Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis 著者: Féline P B Kroon, Robert Landewé, Maxime Dougados, Désirée van der Heijde

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Assessment of progression in knee osteoarthritis: results of a 1 year study comparing arthroscopy and MRI

    Assessment of progression in knee osteoarthritis: results of a 1 year study comparing arthroscopy and MRI 著者: É. Pessis, Jean‐Luc Drapé, Philippe Ravaud, A. Chevrot, Maxime Dougados, X Ayral

    出版事項 2003
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Low plasma androgens in women with active or quiescent systemic lupus erythematosus

    Low plasma androgens in women with active or quiescent systemic lupus erythematosus 著者: Paul Jungers, K Nahoul, C Pélissier, Maxime Dougados, F Tron, Jean‐François Bach

    出版事項 1982
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study

    Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study 著者: Anne Durnez, S. Paternotte, J. Fechtenbaum, Robert Landewé, Maxime Dougados, Christian Roux, Karine Briot

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs

    A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs 著者: Lars Klareskog, M. Gaubitz, Vicente Rodríguez‐Valverde, Michel Malaise, Maxime Dougados, Joseph Wajdula

    出版事項 2006
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

    Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? 著者: Andrei Călin, Jean‐Pierre Nakache, Antoine Guéguen, H. Zeidler, Herman Mielants, Maxime Dougados

    出版事項 1999
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Metabolic bone assessment in patients with inflammatory bowel disease

    Metabolic bone assessment in patients with inflammatory bowel disease 著者: Véred Abitbol, Christian Roux, Stanislas Chaussade, S Guillemant, S. Kolta, Maxime Dougados, Daniel Couturier, B Amor

    出版事項 1995
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: